Evidence map›Paper›PMID 28956778›Full record

ArticleJournal of virology2017

Correction for Spurrell et al., "STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus".

Emma Spurrell, Rathi Gangeswaran, Pengju Wang, Fengyu Cao, Dongling Gao, Baisui Feng, William Wold, Ann Tollefson, Nicholas R Lemoine, Yaohe Wang

Abstract readPublished Erratum
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Emma SpurrellCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Rathi GangeswaranCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Pengju WangSino-British Research Centre for Molecular Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fengyu CaoSino-British Research Centre for Molecular Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Dongling GaoSino-British Research Centre for Molecular Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Baisui FengSino-British Research Centre for Molecular Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
William WoldDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Ann TollefsonDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Nicholas R LemoineCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Yaohe WangCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28956778
PMCPMC5625500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.